Intercontinental Chinese-European Comparison on Surgeon-modified Fenestrated Endografts Vs Hybrid Management of Aortic Arch Diseases

Chang Shu,Beatrice Fiorucci,Kun Fang,Gioele Simonte,Ming Yao Luo,Massimo Lenti,Enrico Cieri
DOI: https://doi.org/10.1016/j.ejvs.2019.06.1054
IF: 6.427
2019-01-01
European Journal of Vascular and Endovascular Surgery
Abstract:Introduction - Cervical debranching followed by implantation of a thoracic aortic stent graft (TEVAR) has been widely adopted to overcome the high surgical stress of total open arch repair, but it might be associated to specific complications as stroke and nerve injuries. Fenestrated and branched TEVAR is emerging as a strategy for the treatment of aortic arch pathologies. The implantation of surgeon modified endografts for the thoracic aorta is nowadays adopted in eastern countries, where the high load of acute aortic arch pathologies renders the prompt availability of endografts mandatory. Methods - Observational study including patients undergoing hybrid procedures and fenestrated surgeon-modified TEVAR for different aortic arch pathologies at two high volume centers. Outcomes of the study were perioperative (<30 days) major complications and endoleaks. Results - 22 patients underwent fenestrated TEVAR with implantation of a surgeon-modified stent-graft (group A) (Fig.1) and 51 patients underwent cervical debranching and TEVAR (group B). Patients in group B resulted significantly older than group A (mean age 60 vs 57, p=.002), and more often affected by respiratory disease (54.3% vs 9.5%, p=.0001). Indications for treatment included aortic dissections, penetrating aortic ulcers, traumatic injuries, aneurysms. With respect to the intraoperative details, contrast medium (177 ml vs 101 ml, p=.0001) resulted lower in group A, while fluoroscopy time did not significantly differ between groups. In one case in group A, left carotid-subclavian by pass was performed as a bailout procedure due to the impossibility to perform an in-situ fenestration due to severe tortuosity of the left subclavian. With respect to perioperative (<30 days) systemic complications, no significant difference has been detected between groups. No cases of stroke have been detected in group A, while one case has been recorded in group B (0% vs 2.2%, p=ns). Similarly, one transient ischemic attack (TIA) occurred perioperatively in group B and none in group A (0% vs 2.2%, p=ns). Postoperative computed tomography angiography (CTA) revealed a major endoleak in 2 cases after fenestrated TEVAR (type 3 endoleak from the fenestration of the graft, 9% of cases) and in 2 cases after hybrid treatment (two type 1 endoleaks requiring reintervention, 3.9%). Type 2 endoleaks were detected in one case in group A (4.5%) and in two cases in group B (3.8%). In one case in group B, the type 2 endoleak required reintervention due to aneurysm growth. Conclusion - The use of surgeon-modified thoracic stent-grafts resulted to be associated with low perioperative systemic complications and low neurological complications, challenging the outcomes of patients treated with hybrid procedures. Longer follow up and further investigations are required to compare more efficiently the two techniques in terms of reinterventions and endoleaks.
What problem does this paper attempt to address?